Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Sources Sought opportunity was posted on February 13, 2017. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Reagents and consumables for Ventana Medical Systems (VMS) Benchmark Ultra immunostainers

Awarded
N02PCSS213-17Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413
New
DIBBS
CULTURE MEDIUM, THAYER-
Solicitation # SPE2DS-27-T-1066
Solicitation SPE2DS-27-T-1066 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one package of Thayer-Martin Modified (MTM II) Agar culture medium, identified by NSN 6550-01-711-1542. This dark brown, ready-to-use plated medium is specifically designed for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and fungi. The product is delivered in packages of 100 plates and requires strict refrigeration storage between 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit) and must not be frozen. The contract mandates a non-extendable shelf life of three months, with a requirement that no more than 14 days elapse between the date of manufacture and the date of delivery to the government. Delivery is set for JBER, Alaska, with a required delivery date of October 27, 2026, under FOB Destination terms. Packaging must be commercial and sealed to prevent damage, with marking adhering to Medical Marking Standard No. 1 and shelf-life labels following MMS1C. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including the Buy American Act, Berry Amendment, and safeguarding of covered defense information. Evaluation will consider technical data for any alternate products offered and may include HUBZone price evaluation preferences. Inspection and acceptance will occur at the destination.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

1 day ago

DEADLINE

in 4 days
NAICS: 325413
New
Federal
6550--Optilite analyzer reagents
Solicitation # 36C26227Q0052
The Department of Veterans Affairs, Southern Arizona Healthcare System, is soliciting a Firm-Fixed Price Blanket Purchase Agreement under solicitation 36C26227Q0052 for the procurement of FDA-approved reference testing reagents and consumables validated for use on the Optilite analyzer. The scope includes specific items such as Freelite Kappa, Freelite Lambda, and Ceruloplasmin reagents, as well as TENCELL cuvettes and sample cups. To ensure system performance and safety, all materials must be manufactured by Binding Site Laboratories, and substitutions are prohibited. The contract is issued as a full and open competition under NAICS code 325413, with a total estimated period of performance of sixty months, consisting of a base period from November 9, 2026, to November 8, 2027, followed by four one-year option periods. The award will be granted to the responsible offeror whose proposal is most advantageous to the government, based on a technical acceptability review of the Statement of Work and the lowest price. Deliveries are required to be made to various VA Medical Centers across Arizona, California, and New Mexico, with standard orders delivered within four working days of placement. All shipments must be destination-based, with the vendor assuming all shipping costs and adhering to strict packaging standards to prevent damage. Invoicing is handled electronically through the Department of Veterans Affairs Financial Services Center in accordance with the Prompt Payment Act. Quotes must be submitted via email to Contract Specialist Carlos Magana by November 4, 2026.
262-NETWORK Contract Office 22 (36C262)

POSTED

3 days ago

DEADLINE

in 5 days
NAICS: 325413
New
Federal
BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems
Solicitation # HT942627QE003
The Defense Health Agency is soliciting quotations to establish a Blanket Purchase Agreement (BPA) for the recurring resupply of consumable products for three Terumo Trima Accel Blood Collection Systems used by the USAISR Combat Casualty Care Research Team 1 in Texas. To maintain FDA approval and satisfy research protocols, the contractor must provide original manufacturer-supplied consumables, including Teruflex 500ml collection bags, Trima Platelet Kits, Isoplate Solution (PAS-F), TSCD Wafers, ACD-A Solution, and 150 mL couplers. This procurement is a 100 percent set-aside for Service-Disabled Veteran-Owned Small Businesses under NAICS 325413. The resulting BPA will have a 60-month ordering period with a total ceiling of 35 million dollars, though some documentation notes a lower limit of 350,000 dollars. Individual call orders are capped at 50,000 dollars, while Government Purchase Card orders are limited to 15,000 dollars. Awards will be made on a Lowest Price Technically Acceptable basis, with technical capability rated as pass or fail. All payment requests and receiving reports must be processed electronically through the Wide Area WorkFlow system. Quotations are due by November 6, 2026, and must be submitted in two separate volumes covering technical capability and pricing.
Army Medical Resources Acq Activity

POSTED

7 days ago

DEADLINE

in 7 days
NAICS: 325413
Federal
6550--VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ
Solicitation # 36C24527Q0042
The Department of Veterans Affairs, specifically the VA North Atlantic Health Network (HSA 1.3), is soliciting a firm-fixed-price, Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Cepheid GeneXpert testing supplies. This requirement covers the procurement of FDA-approved reagents, consumables, and service for PCR analyzers to detect various pathogens, including CoV-2, Influenza, RSV, MRSA, and Mycobacterium Tuberculosis. The contract is structured with a base period ending October 31, 2027, and three subsequent one-year option periods extending through October 31, 2030. Deliveries will be made to multiple VA Medical Centers across Maryland, West Virginia, and Washington DC. This acquisition is set aside for HUBZone small businesses. Award will be determined using the Lowest Price Technically Acceptable (LPTA) method, evaluating technical acceptability, delivery performance, past performance, and price, with additional credit given to certified SDVOSB or VOSB offerors. Key contractor requirements include being an authorized distributor, acknowledging orders within 24 hours, and guaranteeing a minimum four-month expiration date on reagents. Additionally, the vendor must provide an emergency plan to deliver replacement supplies within 24 hours if products are found to be defective. Invoices must be submitted electronically, and payments will be processed in accordance with the Prompt Payment Act.
245-NETWORK Contract Office 5 (36C245)

POSTED

8 days ago

DEADLINE

in 6 days

AI Contract Overview

Show more

The National Cancer Institute is issuing a Sources Sought Notice to identify capable businesses for an indefinite delivery, indefinite quantity contract to provide reagents and consumables for Ventana Ultra automated stainers. The selected contractor will support immunohistochemical assays for clinical trials by providing discounted pricing on supplies, access to updated protocols and software, and technical consultation. Key requirements include ensuring reagents have a minimum six-month shelf life upon delivery, providing overnight shipping, and performing annual preventative maintenance on four stainers, including the free replacement of non-consumable parts. The anticipated contract structure consists of a 12-month base period with four optional 12-month extensions, utilizing firm fixed priced task orders. Deliveries are expected within five days of a task order receipt. Interested parties must submit a capability statement of no more than 10 pages by February 22, 2017, and must maintain active registration in the System for Award Management. This notice is for planning purposes to determine the appropriate acquisition method and does not constitute a formal solicitation or obligation for award.

General Info

Agency

N/A

Contract Value

$38,732.19

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

IN, USA

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded
Posted

Sources Sought

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A

Full Description

Show more
This Sources Sought Notice is for information and planning purposes only and shall not be construed as a solicitation or as an obligation on the part of the National Cancer Institute (NCI). The purpose of this Sources Sought Notice is to identify businesses that are interested in and capable of performing the work described herein. The NCI does not intend to award a contract on the basis of responses received nor otherwise pay for the preparation of any information submitted. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. This requirement is assigned North American Industry Classification System (NAICS) code 325413 with a size standard of 1,250. The Laboratory of Pathology / Center for Cancer Research (CCR) / NCI has a need to provide immunohistochemical assays on formalin-fixed, paraffin embedded tissue sections from patients enrolled on clinical trials in the NCI and other Institutes. Immunohistochemistry is a widespread and accepted technique used in nearly every diagnostic pathology laboratory and in research laboratories throughout the world. These assays have become an essential part of cancer diagnosis and treatment, and have an equally important role in the diagnosis of many infectious diseases. THE CONTRACTOR SHALL: a. Provide a discounted price for the reagents and consumables required in the use of the Ventana Ultra automated stainers b. Provide access to the latest reagents, consumables, optimized protocols, instrument improvement and/or new or updated instrument software c. Be responsible for shipping all eligible reagents, kits and supplies with expiration dates greater than 6 months beyond each shipping date d. The contractor warrants that all reagents delivered shall perform to industry specifications and any defective reagents shall be replaced at no cost to the Government. The contractor shall provide access to scientists and engineers for consultation on procedures and instrumentation. Contractor shall repair or replace free of charge any non-consumable part which fails during the term of this contract, with the exception of equipment damaged by accident, abuse, misuse or misapplication. This includes annual preventative maintenance of each of the four stainers. e. Ship all reagents overnight on dry ice, wet ice or conditions according to the standard commercial shipping practices for each product. CONTRACT TYPE The anticipated award shall be an indefinite delivery, indefinite quantity (IDIQ) contract with firm fixed priced task orders. PERIOD OF PERFORMANCE The period of performance for this contract includes a 12-month base period and four 12-month option periods. The anticipated period of performance shall be 12 months from the date of award. PLACE OF PERFORMANCE Reagents and consumables shall be delivered the address on the delivery/task order. GOVERNMENT FURNISHED EQUIPMENT None OTHER UNIQUE REQUIREMENTS OR CONSIDERATIONS None DELIVERY AND ACCEPTANCE Time of Delivery: Unless a delivery/task order specifies a different delivery time, the Contractor shall deliver reagents within five (5) days or after receipt of each delivery/task order. 1. Satisfactory performance of this contract shall be deemed to occur upon the Contractor's delivery and acceptance by the NCI Contracting Officer, or the duly authorized representative. The NCI Contracting Officer or the duly authorized representative will perform an inspection and acceptance of materials and services provided. Inspection and acceptance shall be performed at the address of the duly authorized representative. Acceptance may be presumed unless otherwise indicated in writing by the NCI Contracting Officer or duly authorized representative within 30 days of delivery. 2. The Contractor shall make required deliveries f.o.b. destination with the consignee's premised address as it is provided by the NCI Purchasing Agent. 3. Unless otherwise specified, deliveries shall be made to the delivery point provided by the Purchasing Agent, Mondays through Fridays (excluding Federal holidays) between the hours of 8:30 a.m. EST and 3:30 p.m. EST only. The product(s) shall be delivered to the address stated on the delivery/task order: Complete building and room details shall be provided on the delivery/task orders when placed against the contract. How to Submit a Response: 1. Page Limitations: Interested qualified businesses/organizations should submit a tailored capability statement for this requirement not to exceed 10 single sided pages including all attachments, resumes, charts, etc. (single spaced, 12 point font minimum) that clearly details the ability to perform the requirements of the notice described above. All proprietary information should be marked as such. 2. Due Date: Capability statements are due no later than February 22, 2017 by 4:00 pm Eastern Time 3. Delivery Point: All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the unique specifications described herein. All questions must be in writing and emailed to contact@example.gov. A determination by the Government not to compete this requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the System for Award Management (SAM) through www.sam.gov. No collect calls will be accepted. Please reference number N02PCSS213-17 on all correspondence. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a RFQ may be published in Fed Biz Opps. However, responses to this notice will not be considered adequate responses to a solicitation(s). Point of Contact: Inquiries concerning this Notice may be direct to: Jolomi Omatete at contact@example.gov. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation.

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS